Patent · US Active

Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood

US9945873B2 · kind B2 · utility

0Cited by
1References
1Claims
0Family size

Assignees

Inventor

Key dates

Filing dateJan 20, 2012
Grant dateApr 17, 2018
Priority date
Expiry dateJan 18, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/50
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient. More particularly, the present invention relates to a method for predicting the risk of having an organ failure selected from the group consisting of respiratory failure, renal failure and thrombopenia in a septic patient comprising a step consisting of measuring the concentration of endocan in a blood sample obtained from said septic patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.